ProShares UltraShort NASDAQ Biotechnology
15 hedge funds and large institutions have $17M invested in ProShares UltraShort NASDAQ Biotechnology in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
15
Holders Change
-4
Holders Change %
-21.05%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
2
Reduced
7
Closed
6
Calls
$8.94M
Puts
$4.65M
Net Calls
+$4.3M
Net Calls Change
-$15.6M
Top Buyers
1 |
EM
1
Emancipation Management
New York
|
$643K |
2 |
MC
2
Moors & Cabot
Boston,
Massachusetts
|
$213K |
3 |
3
Citadel Advisors
Miami,
Florida
|
$2.31M |
4 |
4
UBS Group
Zurich,
Switzerland
|
$92K |